| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX005 (ip) | median survival time | saline | 0.52 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
| Q04DX005 (ip) | median survival time | saline | 0.86 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
| Q04DX005 (ip) | median survival time | saline | 1.44 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
| Q04DX005 (ip) | median survival time | saline | 2.4 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
| Q04DX005 (ip) | median survival time | saline | 4.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
| Q04DX005 (ip) | median survival time | saline | 6.67 mg/kg/injection | 243.0 | Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |